Overview
Angelica Llerenas-Angeles practices practicing medicine in Cuernavaca, Mexico.
Her clinical expertise encompasses Breast Cancer, Menopause, and Obesity.
She is actively involved in clinical research, co-authoring 46 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Angelica R. Llerenas-Angeles
Is Angelica R. Llerenas-Angeles a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Angelica R. Llerenas-Angeles is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Angelica R. Llerenas-Angeles participate in research or clinical trials?
Yes. Angelica R. Llerenas-Angeles has published 46 articles and abstracts on conditions like Breast Cancer. You can view a list of Angelica R. Llerenas-Angeles's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMs. Llerenas-Angeles isExperienced. Learn about Breast Cancer.
- MenopauseMs. Llerenas-Angeles isExperienced. Learn about Menopause.
- ObesityMs. Llerenas-Angeles isExperienced. Learn about Obesity.